Web8. apr 2024 · La spécialité PHESGO (pertuzumab/trastuzumab), administrée par voie sous-cutanée, est une alternative à l’association libre des deux principes actifs déjà disponibles isolément : PERJETA (pertuzumab) et HERCEPTIN (trastuzumab), en première ligne du cancer du sein métastatique HER2 positif. Service Médical Rendu (SMR) WebKaždý ml roztoku obsahuje 60 mg pertuzumabu a 60 mg trastuzumabu. P hesgo 1 200 mg/600mginjekčný roztok. Jedna injekčná liekovka s 15 ml roztoku obsahuje 1 200 mg …
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
WebPhesgo is a clear to opalescent solution, colourless to slightly brownish solution supplied in sterile, preservative-free, non-pyrogenic single-dose vials. WebPHESGO for anaphylaxis, angioedema, interstitial pneumonitis, or acute respiratory distress syndrome. Monitor patients until symptoms completely resolve [see Warnings and … tenshey
Quadintel Global Industry Analysis Report Business Consulting …
Webجميع الحقوق محفوظة © الهيئة العامة للغذاء والدواء © 2024 سياسة الخصوصية; سياسة الإستخدام ... WebPHESGO is compatible with stainless steel, polypropylene, polycarbonate, polyethylene, polyurethane, polyvinyl chloride, and fluorinated ethylene polypropylene. Do not dilute … WebACTEMRA® (tocilizumab) ALECENSA® (alectinib) Avastin® (bevacizumab) COTELLIC® (cobimetinib) ENSPRYNG® (satralizumab-mwge) Erivedge® (vismodegib) Esbriet® (pirfenidone) Evrysdi® (risdiplam) GAVRETO® (pralsetinib) GAZYVA® (obinutuzumab) HEMLIBRA® (emicizumab-kxwh) Herceptin® (trastuzumab) Herceptin HYLECTA™ … triangle march for babies